RecruitingNot ApplicableNCT05915663

Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia

Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia and Other Complications in the Intensive Care Unit


Sponsor

Centre Hospitalier le Mans

Enrollment

2,400 participants

Start Date

Nov 7, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

In intensive care, many gastric tubes are inserted on a regular basis. There are different practices in terms of the location of the gastric tube. In some cases, the tube is inserted through the nose and in others, it is inserted through the mouth. In the literature and in practice, these gastric tubes create discomfort and complications that have an impact not only on the patient, but also on the treatments and the length of the patient's stay in hospital. Nosocomial Ventilator Associated Pneumonia is the most serious common complication for patients intubated with a gastric tube. It is possible that placement site may have an impact on the risk of developing Ventilator Associated Pneumonia, particularly by increasing the risk of bacterial pullulation opposite the sinuses when the tube is placed via the nasal route. Investigator hypothesises that placing the gastric tube orally will reduce the rate of ventilator-associated pneumonia compared with the nasal route in mechanically ventilated intensive care patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying nasogastric tube and orogastric tube and orogastric tube and nasogastric tube for people with intubated patient requiring a gastric tube. The study is currently recruiting participants at 16 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERnasogastric tube and orogastric tube

nasogastric tube in period 1 and orogastric tube in period 2

OTHERorogastric tube and nasogastric tube

orogastric tube in period 1 and nasogastric tube in period 2


Locations(16)

CHU Angers

Angers, France

CH Cholet

Cholet, France

CHU Grenoble

Grenoble, France

CHD Vendée

La Roche-sur-Yon, France

Centre Hospitalier Du Mans

Le Mans, France

APHM - Hôpital Nord

Marseille, France

CHU Nantes

Nantes, France

CHRU Orléans

Orléans, France

APHP - Hôpital Saint-Antoine

Paris, France

CH Périgueux

Périgueux, France

CHU Poitiers

Poitiers, France

CHU Rennes

Rennes, France

CH Saint-Nazaire

Saint-Nazaire, France

CHRU Strasbourg - Hôpital de Hautepierre

Strasbourg, France

CHIC Toulon - La Seyne sur Mer

Toulon, France

CHRU Tours - Hôpital Bretonneau

Tours, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05915663